A Phase 1 Study of DI17E6, an Antibody Targeting AV Integrins, in Progressive Castrate-resistant Prostate Cancer With Bone Metastases (mCRPC) After Chemotherapy
Dokumenttyp:
Meeting Abstract
Autor(en):
Wirth, M; Heidenreich, A; Gschwend, JE; Gil, T; Zastrow, S; Laniado, M; Bernard, L; Vardar, T; Uhl, W; Lannert, H